𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination adefovir–lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B

✍ Scribed by David Van Der Poorten; Emilia Prakoso; Teh-Liane Khoo; Meng C Ngu; Geoffrey W McCaughan; Simone I Strasser; Alice U Lee

Book ID
108951540
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
107 KB
Volume
22
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dynamics of lamivudine-resistant hepatit
Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy
✍ Samreen Ijaz; Catherine Arnold; Samir Dervisevic; Jana Mechurova; Nick Tatman; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Adefovir dipivoxil has been used alone or together with lamivudine to suppress lamivudine‐resistant hepatitis B virus (HBV). However, the dynamics of HBV populations under different selection pressures and their impact on treatment outcome are poorly understood. Pyrosequencing® was appl

Antiviral efficacy of combination therap
Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance
✍ Hyo-Joon Yang; Jeong-Hoon Lee; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract There is little clinical information on the management of hepatitis B virus (HBV) that is resistant to multiple drugs including entecavir (ETV). The present retrospective cohort study assessed the antiviral efficacy of ETV/adefovir dipivoxil (ADV) combination therapy for ETV‐resistant H

Susceptibility of hepatitis B virus to l
Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir
✍ H.L. Zaaijer; R.B. Takkenberg; C.J. Weegink; S.P.H. Rebers; S. Menting; H.W. Ree 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract Serial monotherapy and add‐on regimes for treatment of chronic hepatitis B virus (HBV) infection may induce the accumulation of viral resistance mutations in patients, reducing the options for ongoing viral suppression. The induction of antiviral resistance by serial application of poly